Close Menu

NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 7 percent year over year increase in its fiscal fourth quarter revenues and a 6 percent increase in fiscal year 2018 revenues.

For the quarter ended Sept. 30, the diagnostics manufacturer reported revenues of $53.1 million compared to $49.7 million in the prior year, beating analysts' consensus estimate of $51.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.